Fund Evaluation Group, LLC

Wealth advisor Mechanical financials specialist (88%) CIK 1356249
League rank
#1142
in Wealth advisor · #3727 overall
Long book
$3.25B
Q1 2026
Positions
73
Top-10 weight
85%
concentration
Last quarter
+11.6%
SPY +14.8%
Turnover
22%
of book per quarter

Strategy in plain words

auto-generated from filings

Fund Evaluation Group, LLC is a wealth-management firm allocating client money, specialised in financials (88% of the long book), running a $3.25B US long book across 73 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is modest: positions are typically held for years. Current anchor positions: ISHARES CORE S&P 500 ETF, ISHARES US TREASURY BOND ETF, SCHWAB US LARGE-CAP GROWTH, SCHWAB US LARGE-CAP ETF, ISHARES CORE INTL STOCK ETF.

Over the last 9 quarters its long book ran on average 0.6pp per quarter behind the S&P 500, beating the index in 2 of 9 quarters. Its holdings are mechanical (indexing / client flows), so position changes carry no stock-picking signal.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
+3.5%
Q2 2024
+5.4%
Q3 2024
+1.6%
Q4 2024
-3.4%
Q1 2025
+9.8%
Q2 2025
+6.8%
Q3 2025
+2.4%
Q4 2025
-3.0%
Q1 2026
+11.6%

Sector allocation

Technology
89%
Healthcare
11%

Long book by quarter

$1.60B
Q1 2024
$1.63B
Q2 2024
$1.81B
Q3 2024
$2.14B
Q4 2024
$2.31B
Q1 2025
$2.59B
Q2 2025
$2.76B
Q3 2025
$3.02B
Q4 2025
$3.25B
Q1 2026

What does Fund Evaluation own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
AAPL APPLE INCTechnology1.6K$415K0.0%+2.5%
NVDA NVIDIA CORPTechnology1.4K$236K0.0%Held
FBLG FIBROBIOLOGICS INCHealthcare51.8K$68K0.0%New
ELUT ELUTIA INCHealthcare12.6K$13K0.0%New

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 8, 202673$3.25B canonicalSEC ↗
Q4 202513F-HRFeb 11, 202662$3.02B canonicalSEC ↗
Q3 202513F-HRNov 12, 202575$2.76B canonicalSEC ↗
Q2 202513F-HRAug 7, 202579$2.59B canonicalSEC ↗
Q1 202513F-HRApr 29, 202548$2.31B canonicalSEC ↗
Q4 202413F-HRFeb 12, 202538$2.14B canonicalSEC ↗
Q3 202413F-HRNov 12, 202433$1.81B $K fixed canonicalSEC ↗
Q2 202413F-HR/ARESTATEMENTSep 9, 202432$1.63B $K fixed canonicalSEC ↗
Q2 202413F-HRAug 6, 202433$1.6M SEC ↗
Q1 202413F-HRMay 8, 202438$1.60B $K fixed canonicalSEC ↗